BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heaton SM. Harnessing host-virus evolution in antiviral therapy and immunotherapy. Clin Transl Immunology 2019;8:e1067. [PMID: 31312450 DOI: 10.1002/cti2.1067] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Prathapan P. A determination of pan-pathogen antimicrobials? Medicine in Drug Discovery 2022. [DOI: 10.1016/j.medidd.2022.100120] [Reference Citation Analysis]
2 Perčulija V, Lin J, Zhang B, Ouyang S. Functional Features and Current Applications of the RNA-Targeting Type VI CRISPR-Cas Systems. Adv Sci (Weinh) 2021;8:2004685. [PMID: 34254038 DOI: 10.1002/advs.202004685] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
3 N JB, Goudgaon N. A comprehensive review on pyrimidine analogs-versatile scaffold with medicinal and biological potential. Journal of Molecular Structure 2021;1246:131168. [DOI: 10.1016/j.molstruc.2021.131168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
4 Dubey AK, Chaudhry SK, Singh HB, Gupta VK, Kaushik A. Perspectives on nano-nutraceuticals to manage pre and post COVID-19 infections. Biotechnol Rep (Amst) 2022;33:e00712. [PMID: 35186674 DOI: 10.1016/j.btre.2022.e00712] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
5 Navare AT, Mast FD, Olivier JP, Bertomeu T, Neal M, Carpp LN, Kaushansky A, Coulombe-Huntington J, Tyers M, Aitchison JD. Viral protein engagement of GBF1 induces host cell vulnerability through synthetic lethality. bioRxiv 2020:2020. [PMID: 33173868 DOI: 10.1101/2020.10.12.336487] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Heaton SM. Frontiers in antiviral therapy and immunotherapy. Clin Transl Immunology 2020;9:e1115. [PMID: 32099652 DOI: 10.1002/cti2.1115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Han Z, Ye H, Liang J, Shepley-McTaggart A, Wrobel JE, Reitz AB, Whigham A, Kavelish KN, Saporito MS, Freedman BD, Shtanko O, Harty RN. Compound FC-10696 Inhibits Egress of Marburg Virus. Antimicrob Agents Chemother 2021;65:e0008621. [PMID: 33846137 DOI: 10.1128/AAC.00086-21] [Reference Citation Analysis]
8 Goulding LV, Yang J, Jiang Z, Zhang H, Lea D, Emes RD, Dottorini T, Pu J, Liu J, Chang KC. Thapsigargin at Non-Cytotoxic Levels Induces a Potent Host Antiviral Response that Blocks Influenza A Virus Replication. Viruses 2020;12:E1093. [PMID: 32992478 DOI: 10.3390/v12101093] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Li G, Xu M, Yue T, Gu W, Tan L. Life-long passion for antiviral research and drug development: 80th birthday of Prof. Dr. Erik De Clercq. Biochem Pharmacol 2021;185:114485. [PMID: 33617841 DOI: 10.1016/j.bcp.2021.114485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Mandilara G, Koutsi MA, Agelopoulos M, Sourvinos G, Beloukas A, Rampias T. The Role of Coronavirus RNA-Processing Enzymes in Innate Immune Evasion. Life (Basel) 2021;11:571. [PMID: 34204549 DOI: 10.3390/life11060571] [Reference Citation Analysis]
11 Bao H, Li G, Fang Y, Lai Q, Bao H, Zheng Y, Hu Y. Immunosuppression and cardiovascular dysfunction in patients with severe versus mild coronavirus disease 2019: a case series. Clin Transl Immunology 2020;9:e1188. [PMID: 33024561 DOI: 10.1002/cti2.1188] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Zhang LK, Sun Y, Zeng H, Wang Q, Jiang X, Shang WJ, Wu Y, Li S, Zhang YL, Hao ZN, Chen H, Jin R, Liu W, Li H, Peng K, Xiao G. Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension. Cell Discov. 2020;6:96. [PMID: 33349633 DOI: 10.1038/s41421-020-00235-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
13 Zhao S, Cui H, Hu Z, Du L, Ran X, Wen X. Senecavirus A Enhances Its Adaptive Evolution via Synonymous Codon Bias Evolution. Viruses 2022;14:1055. [DOI: 10.3390/v14051055] [Reference Citation Analysis]
14 Mast FD, Navare AT, van der Sloot AM, Coulombe-Huntington J, Rout MP, Baliga NS, Kaushansky A, Chait BT, Aderem A, Rice CM, Sali A, Tyers M, Aitchison JD. Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality. J Cell Biol 2020;219:e202006159. [PMID: 32785687 DOI: 10.1083/jcb.202006159] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
15 Liu X, Huuskonen S, Laitinen T, Redchuk T, Bogacheva M, Salokas K, Pöhner I, Öhman T, Tonduru AK, Hassinen A, Gawriyski L, Keskitalo S, Vartiainen MK, Pietiäinen V, Poso A, Varjosalo M. SARS-CoV-2-host proteome interactions for antiviral drug discovery. Mol Syst Biol 2021;17:e10396. [PMID: 34709727 DOI: 10.15252/msb.202110396] [Reference Citation Analysis]
16 Saygili E, Yildiz-Ozturk E, Green MJ, Ghaemmaghami AM, Yesil-Celiktas O. Human lung-on-chips: Advanced systems for respiratory virus models and assessment of immune response. Biomicrofluidics 2021;15:021501. [PMID: 33791050 DOI: 10.1063/5.0038924] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
17 [DOI: 10.1101/2020.04.08.20047134] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Reference Citation Analysis]